Interpace Biosciences
IDXG
#10519
Rank
S$45.97 M
Marketcap
S$7.79
Share price
-3.20%
Change (1 day)
510.95%
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): S$5.19 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are S$36.14 Million. In 2025 the company made an earning of S$5.07 Million a decrease over its 2024 earnings that were of S$11.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$5.19 M2.36%
2025 S$5.07 M-54.26%
2024 S$11.1 M303.23%
2023 S$2.75 M-144.63%
2022 -S$6.17 Million-60.98%
2021 -S$15.82 Million-52.04%
2020 -S$32.97 Million-2.68%
2019 -S$33.88 Million121.84%
2018 -S$15.27 Million-6.07%
2017 -S$16.26 Million96.31%
2016 -S$8.28 Million-86.7%
2015 -S$62.28 Million382.48%
2014 -S$12.91 Million134.35%
2013 -S$5.51 Million323.89%
2012 -S$1.3 Million-79.01%
2011 -S$6.19 Million29.08%
2010 -S$4.8 Million-82.57%
2009 -S$27.52 Million-39.28%
2008 -S$45.32 Million146.45%
2007 -S$18.39 Million-269.18%
2006 S$10.86 M-131.08%
2005 -S$34.97 Million-177.16%
2004 S$45.31 M78.33%
2003 S$25.41 M-142.02%
2002 -S$60.48 Million-469.63%
2001 S$16.36 M-68.92%
2000 S$52.63 M140.45%
1999 S$21.89 M
1997 S$3.09 M